PatientsVille.com Logo

PatientsVille

Albyl Side Effects

Common Albyl Side Effects


The most commonly reported Albyl side effects (click to view or check a box to report):

Vomiting (6)
Duodenal Ulcer (5)
Renal Failure Acute (3)
Blood Creatine Phosphokinase Increased (3)
C-reactive Protein Increased (2)
Brain Natriuretic Peptide Increased (2)
Blood Sodium Decreased (2)
Blood Calcium Decreased (2)
Chest Pain (2)
Dehydration (2)
Rhabdomyolysis (2)
Nausea (2)
Gastrointestinal Haemorrhage (2)
Endoscopy Gastrointestinal (2)
Helicobacter Test Positive (1)
Haematemesis (1)
Hepatic Fibrosis (1)
Hypotension (1)
Hypophagia (1)
Hypoglycaemia (1)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Albyl Side Effects Reported to FDA

The following Albyl reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Albyl on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Vomiting, Nausea, Duodenal Ulcer, Dehydration
This is a report of a 88-year-old female patient (weight: NA) from DENMARK, suffering from the following symptoms/conditions: NA, who was treated with Albyl-e (albyl-enterosolubile) (dosage: 75;qd;po, start time: NS), combined with:
  • Glimepiride
  • Loratadine
  • Metformin Hydrochloride (500 Mg;bid;po)
  • Zopiclone
  • Atacand Hct
  • Spironolactone (50 Mg;qd;po)
and developed a serious reaction and side effect(s). The consumer presented with:
  • Vomiting
  • Nausea
  • Duodenal Ulcer
  • Dehydration
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Albyl-e (albyl-enterosolubile) treatment in female patients, resulting in vomiting side effect. The patient was hospitalized.

Occult Blood Positive, Helicobacter Test Positive, Nausea, Vomiting, Dehydration, Duodenal Ulcer
This report suggests a potential Albyl-e (albyl-enterosolubile) Occult Blood Positive, Helicobacter Test Positive, Nausea, Vomiting, Dehydration, Duodenal Ulcer side effect(s) that can have serious consequences. A 88-year-old female patient (weight: NA) from NORWAY was diagnosed with the following symptoms/conditions: NA and used Albyl-e (albyl-enterosolubile) (dosage: 75 Mg (75 Mg, 1 In 1 D), Oral) starting Jul 14, 2011. Soon after starting Albyl-e (albyl-enterosolubile) the patient began experiencing various side effects, including:
  • Occult Blood Positive
  • Helicobacter Test Positive
  • Nausea
  • Vomiting
  • Dehydration
  • Duodenal Ulcer
Drugs used concurrently:
  • Spironolactone (50 Mg (50 Mg, 1 In 1 D), Oral)
  • Glimepiride
  • Zopiclone (zopiclone)
  • Atacand Hct
  • Metformin Hcl (1000 Mg (500 Mg, 2 In 1 D), Oral)
  • Loratidin (loratidine)
The patient was hospitalized. Although Albyl-e (albyl-enterosolubile) demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as occult blood positive, may still occur.

Lactic Acidosis, Vomiting, Renal Failure Acute, Diarrhoea
This Lactic Acidosis, Vomiting, Renal Failure Acute, Diarrhoea problem was reported by a physician from GERMANY. A 55-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On NS this consumer started treatment with Albyl-e (dosage: NA). The following drugs were being taken at the same time:
  • Metoprolol Tartrate
  • Adalat
  • Metformin Hcl (2550mg/day,years)
  • Allopurinol
  • Irbesartan + Hydrochlorothiazide (1 Df : 300/12.5mg,karvea Hct)
  • Persantin
  • Lipitor
When commencing Albyl-e, the patient experienced the following unwanted symptoms/side effects:
  • Lactic Acidosis
  • Vomiting
  • Renal Failure Acute
  • Diarrhoea
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as lactic acidosis, may become evident only after a product is in use by the general population.

Ascites, Gamma-glutamyltransferase Increased, Inflammation, Blood Alkaline Phosphatase Increased, Abdominal Distension, Peritonitis Bacterial, Pleural Effusion, Hepatic Fibrosis
This is a report of a 76-year-old male patient (weight: NA) from NORWAY. The patient developed the following symptoms/conditions: coronary artery disease,systemic sclerosis,diabetes mellitus,cardiac failure and was treated with Albyl-e (dosage: 75 Mg, 1x/day) starting Apr 01, 2006. Concurrently used drugs:
  • Tracleer (62.5 Mg, Bid)
  • Metformin (850 Mg, 1x/day)
  • Lisinopril (5 Mg, 1x/day)
  • Tracleer (125 Mg, Bid)
  • Tracleer (62.5 Mg, Bid)
  • Sildenafil Citrate (25 Mg, Tid)
  • Levothyroxine Sodium (50 Ug, 1x/day)
Soon after that, the consumer experienced the following side effects:
  • Ascites
  • Gamma-glutamyltransferase Increased
  • Inflammation
  • Blood Alkaline Phosphatase Increased
  • Abdominal Distension
  • Peritonitis Bacterial
  • Pleural Effusion
  • Hepatic Fibrosis
The patient was hospitalized. This opens a possibility that Albyl-e treatment could cause the above reactions, including ascites, and some male subjects may be more susceptible.


Blood Creatine Phosphokinase Increased, Renal Failure Acute, Hypophagia, Hypoglycaemia, Myoglobin Blood Increased, Rhabdomyolysis, Fatigue, Urinary Retention, Blood Parathyroid Hormone Increased
A 68-year-old female patient (weight: NA) from with the following symptoms/conditions: NA started Albyl Minor treatment (dosage: NA) on NS. Soon after starting Albyl Minor treatment, the subject experienced various side effects, including:
  • Blood Creatine Phosphokinase Increased
  • Renal Failure Acute
  • Hypophagia
  • Hypoglycaemia
  • Myoglobin Blood Increased
  • Rhabdomyolysis
  • Fatigue
  • Urinary Retention
  • Blood Parathyroid Hormone Increased
Concurrently used drugs:
  • Acetaminophen W/ Codeine
  • Metformin Hcl (2.5g-qd-oral)
  • Triobe
  • Propavan
  • Enalapril Maleate (20mg-daily- )
  • Inderal La
  • Tavegyl
  • Mindiab
The patient was hospitalized. This finding indicates that some female patients could be more vulnerable to Albyl Minor.

Myocardial Infarction, Renal Failure Acute, Acute Hepatic Failure, Rhabdomyolysis
A 71-year-old male patient from NORWAY (weight: NA) experienced symptoms, such as: cardiovascular disorder and was treated with Albyl-e(dosage: NA). The treatment was initiated on Jun 01, 2009. After that a consumer reported the following side effect(s):
  • Myocardial Infarction
  • Renal Failure Acute
  • Acute Hepatic Failure
  • Rhabdomyolysis
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Albyl-e efficacy:
  • Metoprolol Tartrate
  • Mucomyst
  • Lipitor
  • Imurel
  • Diural


Abdominal Pain, Duodenal Ulcer, Vomiting
In this report, Albyl-e was administered for the following condition: atrial flutter,osteoporosis.A 85-year-old female consumer from NORWAY (weight: NA) started Albyl-e treatment (dosage: 75 Mg/day) on Nov 09, 2007.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Abdominal Pain
  • Duodenal Ulcer
  • Vomiting
A possible interaction with other drugs could have contributed to this reaction:
  • Calcigran (500 Mg/day)
  • Flagyl (500 Mg, Tid)
  • Tarivid (200 Mg, Bid)
  • Tramagetic (300 Mg/day)
  • Betolvex
  • Selo-zok (50 Mg/day)
  • Nycoplus Folsyre (0.4 Mg/day)
  • Voltaren (50 Mg, Tid)
The patient was hospitalized.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Albyl-e treatment could be related to the listed above side effect(s).

Blood Calcium Decreased, Blood Creatine Phosphokinase Increased, Blood Sodium Decreased, Brain Natriuretic Peptide Increased, C-reactive Protein Increased, Chest Pain, Duodenal Ulcer, Endoscopy Gastrointestinal, Gastrointestinal Haemorrhage
This is a report of the following Albyl-e side effect(s):
  • Blood Calcium Decreased
  • Blood Creatine Phosphokinase Increased
  • Blood Sodium Decreased
  • Brain Natriuretic Peptide Increased
  • C-reactive Protein Increased
  • Chest Pain
  • Duodenal Ulcer
  • Endoscopy Gastrointestinal
  • Gastrointestinal Haemorrhage
A 83-year-old female patient from NORWAY (weight: NA) presented with the following condition: NA and received a treatment with Albyl-e (dosage: NA) starting: NS.The following concurrently used drugs could have generated interactions:
  • Fosamax
  • Imdur
  • Selo-zok
  • Sarotex
  • Sobril
  • Diclofenac Sodium
The patient was hospitalized.This report suggests that a Albyl-e treatment could be associated with the listed above side effect(s).

Blood Calcium Decreased, Blood Creatine Phosphokinase Increased, Blood Sodium Decreased, Brain Natriuretic Peptide Increased, C-reactive Protein Increased, Chest Pain, Duodenal Ulcer, Endoscopy Gastrointestinal, Gastrointestinal Haemorrhage
This Albyl-e report was submitted by a 83-year-old female consumer from NORWAY (weight: NA). The patient was diagnosed with: NA and Albyl-e was administered (dosage: NA) starting: NS. The consumer developed a set of symptoms:
  • Blood Calcium Decreased
  • Blood Creatine Phosphokinase Increased
  • Blood Sodium Decreased
  • Brain Natriuretic Peptide Increased
  • C-reactive Protein Increased
  • Chest Pain
  • Duodenal Ulcer
  • Endoscopy Gastrointestinal
  • Gastrointestinal Haemorrhage
Other drugs used simultaneously:
  • Fosamax
  • Imdur
  • Selo-zok
  • Sarotex
  • Sobril
  • Diclofenac Sodium
The patient was hospitalized.Those unexpected symptoms could be linked to a Albyl-e treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Abdominal Pain Upper, Gastritis, Gastroduodenitis, Vomiting
This is a report of a possible correlation between Albyl-e use and the following symptoms/side effect(s):
  • Abdominal Pain Upper
  • Gastritis
  • Gastroduodenitis
  • Vomiting
which could contribute to an assessment of Albyl-e risk profile.A 62-year-old male consumer from NORWAY (weight: NA) was suffering from nephrolithiasis and was treated with Albyl-e (dosage: 75 Mg/day) starting Dec 19, 2006.Other concurrent medications:
  • Confortid (100 Mg/day)
  • Morphine
  • Voltaren (100 Mg/day)
The patient was hospitalized.

Anaemia, Gastric Haemorrhage, Gastric Ulcer, Gastritis Erosive, Haematemesis, Hypotension, Melaena
A 85-year-old male patient from NORWAY (weight: NA) presented with the following symptoms: NA and after a treatment with Albyl-e (dosage: 160 Mg, Qd) experienced the following side effect(s):
  • Anaemia
  • Gastric Haemorrhage
  • Gastric Ulcer
  • Gastritis Erosive
  • Haematemesis
  • Hypotension
  • Melaena
The treatment was started on May 22, 2006. Albyl-e was used in combination with the following drugs:
  • Acetaminophen (1 G, Qid)
  • Voltaren (50 Mg, Tid)
This report could alert potential Albyl-e consumers.

Blood Pressure Systolic Increased, Cerebral Haemorrhage, Cerebrovascular Accident, Fall, Neck Pain, Vomiting
In this report, a 71-year-old female patient from NORWAY (weight: NA) was affected by a possible Albyl-e side effect.The patient was diagnosed with headache. After a treatment with Albyl-e (dosage: NA, start date: Dec 17, 2001), the patient experienced the following side effect(s):
  • Blood Pressure Systolic Increased
  • Cerebral Haemorrhage
  • Cerebrovascular Accident
  • Fall
  • Neck Pain
  • Vomiting
The following simultaneously used drugs could have led to this reaction:
  • Evista
  • Activelle
  • Vioxx
  • Vioxx
  • Fosamax
The patient was hospitalized.The findings here stress that side effects should be taken into consideration when evaluating a Albyl-e treatment.



Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Albyl Side Effects

    Did You Have a Albyl Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Albyl for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Albyl Safety Alerts, Active Ingredients, Usage Information

    More About Albyl

    Side Effects reported to FDA: 12

    Albyl safety alerts: No

    Reported deaths: 2

    Reported hospitalizations: 7

    Latest Albyl clinical trials